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Background: Parkinson's disease (PD) is a multifactorial disease where environmental factors act on genetically
predisposed individuals. Although only 5% of PD manifestations are associated with specific mutations, majority of
PD cases are of idiopathic origin, where environment plays a prominent role. Concurrent exposure to Paraquat (PQ)
and Maneb (MB) in rural workers increases the risk for PD and exposure of adult mice to MB/PQ results in
dopamine fiber loss and decreased locomotor activity. While PD is characterized by neuronal loss in the substantia
nigra, we previously showed that accumulation of α-synuclein in the limbic system contributes to
neurodegeneration by interfering with adult neurogenesis.
Results: We investigated the effect of pesticides on adult hippocampal neurogenesis in two transgenic models:
Line 61, expressing the human wild type SNCA gene and Line LRRK2(G2019S), expressing the human LRRK2 gene
with the mutation G2019S. Combined exposure to MB/PQ resulted in significant reduction of neuronal precursors
and proliferating cells in non-transgenic animals, and this effect was increased in transgenic mice, in particular for
Line 61, suggesting that α-synuclein accumulation and environmental toxins have a synergistic effect. We further
investigated the transcription of 84 genes with direct function on neurogenesis. Overexpresion of α-synuclein
resulted in the downregulation of 12% of target genes, most of which were functionally related to cell
differentiation, while LRRK2 mutation had a minor impact on gene expression. MB/PQ also affected transcription in
non-transgenic backgrounds, but when transgenic mice were exposed to the pesticides, profound alterations in
gene expression affecting 27% of the studied targets were observed in both transgenic lines. Gene enrichment
analysis showed that 1:3 of those genes were under the regulation of FoxF2 and FoxO3A, suggesting a primary role
of these proteins in the response to genetic and environmental cues.
Conclusions: We report that adult neurogenesis is highly susceptible to multiple “risk factors” for PD, including
α-synuclein accumulation, LRRK2 G2019 mutation and exposure to environmental toxins. We identified specific
groups of genes that are responsive to each stressor, while uncovering a novel function for Fox transcription factors
in PD.
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Parkinson's disease (PD) is the second most common neu-
rodegenerative disorder in the elderly, affecting 2% of the
population over 60 years old [1]. The classic form of
PD is manifested clinically by resting tremor and pos-
tural instability, along with variable non-motor symp-
toms. Neuropathologically, PD is characterized by the
loss of dopaminergic neurons mainly in the substantia
nigra pars compacta accompanied by the formation of
intracytoplasmic inclusions known as Lewy bodies, con-
taining α-synuclein. Neurodegeneration in PD affects pri-
marily the striatonigral system, but cases with cognitive
impairment present more widespread degeneration in-
cluding neuronal populations in the striatum, hippocam-
pus, and neocortex [2,3]. Therefore, PD associated
pathology not only has an impact on the degeneration of
mature dopaminergic neurons in the basal ganglia, but
could also influence neurogenesis in the adult brain [4],
where neural stem and progenitor cells are still present in
the hippocampal dentate gyrus and the subventricular
zone (SVZ), and continuously generate new neurons [5-7].
From etiology, PD is believed to be a multifactorial
disease where environmental factors might act on genet-
ically predisposed individuals [8]. Only a small fraction
of PD occurrence (about 5 % of cases) are inherited in a
recessive or dominant manner and are associated with
mutations in genes including SNCA, LRRK2, DJ1, PINK1
and UCHL-1 [9,10]. Although mutations in the SNCA
gene (encoding for α-synuclein) are rare, the crucial
roles of α-synuclein in PD pathology, including aberrant
calcium homoeostasis and mitochondrial fragmentation,
is supported by multiple neuropathological and bio-
chemical evidence.
Mutations in the same genes can be involved in famil-
ial PD and also be risk factors for sporadic manifesta-
tions; suggesting that inherited and idiopathic PD share
common pathological mechanisms [11]. While accumu-
lation/missfolding of α-synuclein might play more prom-
inent roles in PD sporadic manifestations, mutations in
the LRRK2 gene, encoding leucine-rich repeat kinase 2,
are the most prevalent cause of autosomal dominantly
inherited PD, which are characterized by brainstem
Lewy body pathology. The most frequent mutation,
LRRK2(G2019S) is located in the kinase domain of the
protein increasing kinase activity [12] and has the high-
est genotype- and population-attributable risk [13].
We have recently shown that accumulation of α-
synuclein in the limbic system might contribute to the
neurodegenerative phenotype by interfering with adult
neurogenesis in transgenic mice models [14,15]. We
reported reduced proliferation and neuronal maturation
accompanied by increased apoptosis in murine embry-
onic stem (mES) cells overexpressing wild type and mu-
tant α-synuclein, and in the hippocampal subgranularzone of α-synuclein transgenic mice. These alterations
were accompanied by a reduction in Notch-1 and Hairy
and Hes-5 mRNA and protein levels [16].
LRRK2 protein, on the other hand, shows widespread,
neuronal-specific expression in the adult mammalian
brain, and is highly expressed in the hippocampus and
subventricular zone (SVZ) [17], suggesting its role in
neurogenesis. LRKK2 have been recently implicated in
modulation of neuronal differentiation in murine embry-
onic stem cells [18]. Moreover, adult neurogenesis and
neurite outgrowth have been reported to be impaired in
LRKK2(G2019S) mice [19].
Besides genetic-linked manifestations, the majority of
PD cases are of idiopathic origin, whose etiology is yet
not completely understood. Recent studies however, sug-
gest that interactions between environmental toxins and
genetic polymorphisms might play a role. Neurotoxins,
including agrichemicals might lead to neurodegeneration
by triggering accumulation of α-synuclein in subcortical
and cortical regions [20]. Concurrent exposure to the
herbicide Paraquat (PQ) and the fungicide Maneb (MB)
in adult mice led to significantly dopamine (DA) fiber
loss, altered DA turnover and decreased locomotor ac-
tivity [21,22]. Moreover, combined exposure to MB and
PQ in rural workers was reported to increase the risk of
developing PD by 75% in agricultural areas of California
[23]. PQ is one the most used herbicides worldwide. PQ
exerts its toxicity by cellular redox cycling with the for-
mation of superoxide radicals and it is believed that
mitochondrial complex I is a primary target [24]. MB,
used as a fungicide, seems to cross the brain blood bar-
rier and, although its mechanisms of toxicity are not
very well known, it seems to preferentially inhibit mito-
chondrial complex III [8].
Although extensive research has been conducted on
the effects of pesticides on the dopaminergic system in
the PD brain, a possible impact of pesticide exposure on
adult neurogenesis remained to be explored.
We extended here our previous studies on adult hippo-
campal neurogenesis [4,14-16,19] in two different trans-
genic mice mouse models of PD generated in our
laboratory, the Line 61, expressing the human wild type
SNCA gene and Line 29 that expresses LRRK2(G2019S),
by investigating the effects of MB and PQ exposure and
with the aim to model gene x environment interactions in
familial and sporadic PD manifestations. Our findings
show that α-synuclein missfoldig/accumulation, LRRK2
gene mutation G2019S and exposure to the agrichemicals
Maneb and Paraquat have deleterious effects on adult
neurogenesis, contributing to overall PD pathology.
Results and discusion
The mThy1- α-synuclein tg (Line 61) expresses high levels
of human α-synuclein throughout the brain, including the
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reproduces some aspects of PD, with progressive changes
in dopamine release and striatal content, α-synuclein
pathology and deficits in motor and non-motor functions
[26]. The mThy1-LRRK2(G2019S) transgenic mice
present a 3 fold overexpression of the transgene in the
neocortex (Additional File 1).
To analyze the effects of fungicides/herbicides on adult
neurogenesis, transgenic animals of both lines and their
non-transgenic littermate controls were administered i.p.
injections of Maneb (15 mg/kg) and Paraquat (5 mg/kg)
or saline (for control groups), twice a week during 21
days. We centered our study on the adult neurogenic
niche in the SVZ by immunohistochemical detection of
neurogenesis markers and by the focused analysis of the
expression of 84 genes related to neurogenesis and
neural stem cell physiology by real time-PCR-arrays.
We first evaluated the effects of MB/PQ exposure on
adult neurogenesis at the cellular level by immunohisto-
chemical detection of neuronal precursors and prolifer-
ating cells in the hippocampus of non-transgenic and
transgenic animals with or without exposure to MB/PQFigure 1 Exposure to Maneb and Paraquat alters adult neurogenesis
Immunohistochemical detection of Doublecortin (DCX) positive neuronal p
proliferating cells (C) in hippocampus of non-transgenic or Line 61 mice ov
counts of DCX (B) and PCNA (D) immunoreactive cells. (F) Optical density a
represents 10 μm. One way ANOVA or Student’s t test was used to determ(Figures 1 and 2). Combined exposure to agrichemicals
resulted in a significant reduction in neuronal precursors
(DCX positive) and proliferating cells (PCNA positive)
in non-transgenic animals (Figure 1A-D and Figure 2A-
D). While overexpression of α-synuclein in Line 61
transgenic animals had minimal effects on neurogenesis
(Figure 1A-D), exposure of these transgenic animals to
MB/PQ resulted in a significant loss of DCX and PCNA
positive cells (Figure1A-D) suggesting that α-synuclein
accumulation and environmental toxins have a synergis-
tic effect. On the other hand, analysis of LRRK2
(G2019S) transgenic mice revealed that the mutation
impacts adult neurogenesis by reduction of neuronal
precursors and proliferating cells (Figure 2A-D), but
these alterations were only slightly increased by subse-
quent exposure to MB/PQ (Figure 2A-D).
We next investigated if transcriptional disregulation
might underlie the observed alterations in neurogenesis.
To analyze the contribution of each genetic background,
we first compared gene expression profiles between trans-
genic animals and their non-transgenic littermates only
treated with saline (Table 1). In agreement with ourin the hippocampus of α-Synuclein transgenic mice.
recursors (A) and Proliferating cell nuclear antigen (PCNA) positive
erexpressing human α-synuclein (E). Image analysis showing total
nalysis showing accumulation of α-synuclein transgenic mice. Bar
ine statistical significance, *, # p<0.05.
Figure 2 Exposure to Maneb and Paraquat alters adult neurogenesis in the hippocampus of LRRK2(G2019S) transgenic mice.
Immunohistochemical detection of Doublecortin (DCX) positive neuronal precursors (A) and Proliferating cell nuclear antigen (PCNA) positive
proliferating cells (C) in hippocampus of non-transgenic or LRRK2(G2019S) mice. Image analysis showing total counts of DCX (B) and PCNA (D)
immunoreactive cells. (E-F) Immunodetection and optical density analysis showing accumulation of phosphorylated Tau characteristic of LRRK2
(G2019S) transgenic mice. Bar represents 10 μm. One way ANOVA or Student’s t test was used to determine statistical significance, *, # p<0.05.
Table 1 Genetic Effects: genes dysregulated in PD transgenic mice models
Accession Fold change Gene title Gene symbol Functional
Group
(A) mThy-α-synuclein transgenic (Line 61)
NM_145990 −1.56 CDK5 regulatory subunit associated protein 2 Cdk5rap2 Cell differentiation
NM_008711 −1.44 Noggin Nog
NM_008380 −1.34 Inhibin beta-A Inhba
NM_010894 −1.26 Neurogenic differentiation 1 Neurod1
NM_009170 −1.21 Sonic hedgehog Shh
NM_008744 −1.33 Netrin 1 Ntn1 Cell motility and migration
NM_021409 −1.30 Par-6 (partitioning defective 6) homolog beta (C. elegans) Pard6b
NM_010275 −1.46 Glial cell line derived neurotrophic factor Gdnf Growth factors
NM_013904 −1.26 Hairy/enhancer-of-split related with YRPW motif 2 Hey2 Transcription
NM_007889 −1.24 Dishevelled 3, dsh homolog (Drosophila) Dvl3 Cell signaling
(B) mThy-LRRK2 mut G2019S (Line G2019S)
NM_145990 1.58 CDK5 regulatory subunit associated protein 2 Cdk5rap2 Cell differentiation
NM_009630 −1.27 Adenosine A2a receptor Adora2a Cell signaling, apoptosis
NM_022312 −1.24 Tenascin R Tnr Cell adhesion
Comparison of gene expression between each of the transgenic lines studied with their corresponding non-transgenic littermates treated with saline. P<0.05 per
Student’s t test.
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NM_007488 1.25 Aryl hydrocarbon receptor nuclear translocator 2 Arnt2 Transcription
NM_194053 1.22 Reticulon 4 Rtn4 Apoptosis
NM_145990 1.24 CDK5 regulatory subunit associated protein 2 Cdk5rap2 Cell differentiation
NM_008380 −1.54 Inhibin beta-A Inhba
NM_008711 −1.27 Noggin Nog
NM_010894 −1.23 Neurogenic differentiation 1 Neurod1
NM_008744 −1.40 Netrin 1 Ntn1 Cell motility
NM_007540 −1.35 Brain derived neurotrophic factor Bdnf Growth factors
NM_022312 −1.23 Tenascin R Tnr Cell adhesion
NM_174991 −1.21 Brain-specific angiogenesis inhibitor 1 Bai1 Cell proliferation
Comparison of gene expression between non-transgenic animals treated with Maneb/Paraquat with non-transgenic animals treated with saline as control group.
P<0.05 per Student’s t test.
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the downregulation of 10 genes of our target panel
(~12%), most of which were functionally related to cell dif-




NM_145990 −2.35 CDK5 regulatory subunit associated protein 2
NM_007865 −1.82 Delta-like 1 (Drosophila)
NM_008380 −1.80 Inhibin beta-A
NM_008711 −1.68 Noggin
NM_010894 −1.33 Neurogenic differentiation 1
NM_009170 −1.33 Sonic hedgehog
NM_008553 −1.26 Achaete-scute complex homolog 1 (Drosoph
NM_008782 −1.24 Paired box gene 5
NM_010275 −1.25 Glial cell line derived neurotrophic factor
NM_009505 −1.33 Vascular endothelial growth factor A
NM_007553 −1.28 Bone morphogenetic protein 2
NM_007554 −1.25 Bone morphogenetic protein 4
NM_010077 −1.31 Dopamine receptor D2
NM_013503 −1.23 Dopamine receptor D5
NM_013904 −1.64 Hairy/enhancer-of-split related with YRPW mo
NM_013905 −1.61 Hairy/enhancer-of-split related with YRPW mo
NM_007889 −1.52 Dishevelled 3, dsh homolog (Drosophila)
NM_001008533 −1.30 Adenosine A1 receptor
NM_008744 −1.39 Netrin 1
NM_174991 −1.28 Brain-specific angiogenesis inhibitor 1
NM_022312 −1.27 Tenascin R
NM_013660 −1.26 Sema domain, Ig domain, transmembrane do
domain, 4D
NM_009685 −1.38 Amyloid beta (A4) precursor protein-binding,
Comparison of gene expression between mThy-α-synuclein transgenic mice treated
treated with saline. P<0.05 per Student’s t test. Bold italic fonts denote genes also aLRRK2(G2019S), on the other hand, had a minor impact
on neurogenesis-related gene expression, with only 3
genes been disregulated (<4%), without functional relation



























main and short cytoplasmic Semad4 Apoptosis
family B,1 Apbb1 Cell cycle
with Maneb/Paraquat, with their corresponding non-transgenic littermates
ffected by genetic background or pesticides independently.
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direct target for environmental toxins by comparing
gene expression levels between non transgenic animals
exposed to MB/PQ to those treated with saline (Table 2).
Exposure to agrichemicals resulted in the altered tran-
scription of another set of 10 genes, half of which over-
lapped with the genes disregulated in the transgenic
models, suggesting that environmental and genetic con-
ditions share common molecular targets. We therefore
analyzed how gene x environment interactions might
potentiate their individual effects on adult neurogenesis.
Comparison of transcriptomes between MB/PQ treated
transgenic animals and non-transgenic saline controls
revealed profound alterations in gene expression for
both lines (Tables 3 and 4). We found that 27% of the
screened genes (23 out of 84) were downregulated in
Line 61 animals (Table 3) and this time, a similar extent
of disregulation was observed for LRRK2(G2019S) mice
treated with MB/PQ, with 22 out of 84 transcripts being
significantly altered (Table 4). As previously observed for
the pesticide exposure, cell differentiation was the most




NM_145990 1.32 CDK5 regulatory subunit associated
NM_178591 −1.37 Neuregulin 1
NM_025876 −1.32 CDK5 regulatory subunit associated
NM_008380 −1.31 Inhibin beta-A
NM_013627 −1.29 Paired box gene 6
NM_010894 −1.26 Neurogenic differentiation 1
NM_009170 −1.24 Sonic hedgehog
NM_009871 −1.22 CDK5 regulatory subunit 1 (p35)
NM_007540 −1.24 Brain derived neurotrophic factor
NM_009505 −1.23 Vascular endothelial growth factor A
NM_007554 −1.23 Bone morphogenetic protein 4
NM_013904 −1.30 Hairy/enhancer-of-split related with
NM_008900 −1.26 POU domain, class 3, transcription fa
NM_007488 −1.24 Aryl hydrocarbon receptor nuclear t
NM_022312 −1.27 Tenascin R
NM_010110 −1.21 Ephrin B1
NM_183171 −1.21 Fasciculation and elongation protein
NM_174991 −1.37 Brain-specific angiogenesis inhibitor
NM_010883 −1.21 Norrie disease (pseudoglioma)
NM_203491 −1.24 Cholinergic receptor, muscarinic 2
NM_009599 −1.21 Acetylcholinesterase
NM_008744 −1.39 Netrin 1
Comparison of gene expression between mThy-LRRK2(G2019) transgenic mice treat
with saline. P<0.05 per Student’s t test. Bold italic fonts denote genes also affectedgrowth factors, transcriptional regulation, synaptic func-
tion and cell adhesion. Only 50% of the altered tran-
scripts were also affected by either genetic or
environmental factors independently, with the remaining
50% of targets being specifically altered in response to
gene x environment interactions.
To determine if common regulatory factors might me-
diate this broad transcriptional disregulation we per-
formed Gene Set Enrichment analysis using the
Molecular Signature Database category C3, “motif-
based” to search for known and likely regulatory ele-
ments present in the promoters and 3’ UTR on our
entire group of 38 affected genes [27]. From the input
list, 34 genes (>89%) were catalogued sequences that
entered the analysis. Significant enrichment was
obtained for FoxF2 that was present in 10 genes
(p<0.001), followed but IPF1, FoxO3A, PIT1, ARNT
and REST (Figure 3). We obtained positive hits for
Fox family members in 12 genes, almost 1:3 of the
altered sequences, suggesting a primary role of these
regulatory proteins in mediating the response of neur-
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Ntn1 Cell motility and migration
ed with Maneb/Paraquat, with their corresponding non-transgenic littermates
by genetic background or pesticides independently.
Figure 3 Gene Set Enrichment analysis of disregulated
transcripts. Gene Set Enrichment analysis was performed using the
Molecular Signature Database “motif-based” to search for known
and likely regulatory elements present in the promoters and 3’ UTR
on our entire group of 38 affected genes. Shadow boxes represent
positive hits for the regulatory proteins on the top row for each
tested gene in the first column with a p<0.001. FOXF2: forkhead box
F2; FOXO3A: forkhead box O3A; IPF1: Insulin promoter factor 1; REST:
RE1-silencing transcription factor; PIT1: POU domain, class1,
transcription factor 1 (Pit1) and ARNT: aryl hydrocarbon receptor
nuclear translocator.
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In conclusion, we report here that adult neurogenesis is
highly susceptible to multiple “risk factors” for PD, includ-
ing α-synuclein accumulation, LRRK2 G2019S mutation
and exposure to environmental toxins, namely the fungi-
cide Maneb and the pesticide Paraquat. Each of these
three factors, either alone or in combination, extensively
affect the expression of genes that regulate stem cellproliferation, fate determination, neuronal differentiation
and survival. Cell differentiation and the expression of
growth factors needed to sustain the new neuronal lineage
appear to be the most affected steps in neurogenesis, thus
aberrant transcription might mediate reduced survival and
integration of newborn neurons into the existing circuit-
ries. Our current results extend previous studies from our
group and others showing that neurogenesis is reduced in
the olfactory bulb and the hippocampus of adult α-
synuclein transgenic mice by diminished survival of neur-
onal precursors [14] and, importantly, that the neurogenic
system is compromised in human PD brains, where prolif-
eration of neural progenitor cells is decreased in the
hippocampus and SVZ [28].
We were able to identify specific groups of genes that
are responsive to genetic variability (α-synuclein accumu-
lation or LRKK2 G2019S mutation); to environmental tox-
ins (MB/PQ exposure) or to the combination of genetic
and environmental factors. Moreover, gene set enrichment
analysis uncovered a novel function for members of the
Fox family of transcription factors in PD. Forkhead box
(Fox) transcription factors belong to a large family of regu-
latory proteins known to be involved in embryonic devel-
opment, cell proliferation and differentiation [29,30].
Different lines of evidence suggest the involvement of par-
ticular Fox proteins in PD pathology: LRRK2 activity is
needed for phosphorylation-dependent activation of FoxO
[31] and ectopic localization of FoxO3a associated with
Lewy bodies has been reported in human postmortem PD
brains [32]. We propose a model integrating well-
characterized molecular pathways leading to PD (Figure 4)
in which MB and PQ interfere with mitochondria triggering
oxidative stress and ROS production (1), which contribute
to the nitrosylation and inactivation of transcription factors
[33] (2), and missfolding and aggregation of proteins, like
α-synuclein. Lewy body formation in association with α-
synuclein aggregation and phosphorylated-Tau accumula-
tion in the context of LRRK2 mutations might also contrib-
ute to misslocalization of Fox proteins (3) or aberrant
phosphorylation triggering apoptosis and neuronal death
(4). In addition, α-synuclein can directly bind to GC rich
DNA regions abundant in promoters [34] and also alters
DNA methylation [35] (5). The combination of these fac-
tors will impact on the transcription of Fox-regulated




Experiments were conducted on 10-month old-transgenic
mice expressing either wild type human SNCA (mthy1-h
α-syn tg) or human LRRK2 harboring the G2019S muta-
tion (mthy1-h LRRK2 mut G2019) under the Thy-1 pro-
moter [25]; and on age and sex matched non-transgenic
Figure 4 Hypothetical model linking gene and environmental factors to transcriptional disregulation of neurogenesis-related genes.
Maneb and Paraquat trigger ROS production (1), nitrosylation of transcription factors (2), and missfolding and aggregation of proteins, like
α-synuclein. Lewy body formation in association with α-synuclein aggregation and phosphorylated-Tau accumulation in the context of LRRK2
mutations might contribute to misslocalization of Fox proteins (3) or aberrant phosphorylation triggering apoptosis and neuronal death (4).
Alpha-synuclein can directly bind DNA and also alter DNA methylation (5). The combination of these factors will impact on the transcription of
Fox-regulated neurogenesis-related genes (6).
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injected intraperitoneally with saline or a sequential com-
bination of Paraquat (5 mg/kg; Sigma) followed by Maneb
(15 mg/kg; Sigma) twice a week for 21 days. Injections
were applied 2 hours apart from each other. Brains were
extracted after cervical dislocation and immediately frozen
or fixed. All animals were handled in strict accordance
with good animal practice and all procedures were com-
pleted under the specifications set forth by the UCSD In-
stitutional Animal Care and Use Committee.Immunohistochemical analysis of neurogenesis markers
Briefly, as described previously [14,15], free-floating
sections from mouse brains were treated with 0.6%
H2O2 in Tris-buffered saline (TBS) (0.15 M NaCl and
0.1 M Tris- HCl, pH 7.5) for 30 min and incubated
with antibodies against proliferating cell nuclear anti-
gen (PCNA) (mouse monoclonal, 1:250; Santa Cruz
Biotechnology), doublecortin (DCX) (goat polyclonal,
1:100; Santa Cruz Biotechnology), α-synuclein (rabbit
polyclonal, 1:500; Millipore Bioscience) or mouse
monoclonal antibody against phosphorylated Tau
(1:250, a kind gift from Dr. Peter Davies at Albert
Einstein, School of Medicine, NYC) overnight at 4°C.
Sections were incubated for 1 h with the correspond-
ing biotinylated secondary antibodies. After rinses in
TBS, avidin– biotin–peroxidase complex was applied
for 1 h, and then peroxidase detection was performed
for 10 min (25 mg/ml diaminobenzidine, 0.01%
H2O2, and 0.04% NiCl in TBS).Real-time PCR analysis
Total RNA was extracted from mice brains using the
RNeasy mini kit (Qiagen, Valencia, CA) and was reverse
transcribed using RT2 First Strand kit (SA Biosciences,
Frederick, MD) from 1 μg of total RNA. Real-time PCR
analysis was performed with the RT2 Profiler PCR Array
for mouse Neurogenesis and Neural Stem Cells (PAMM-
404 SABiosciences) according to the manufacturer’s
instructions and using the StepOnePlusTM real-time PCR
system (Applied Biosystems, Carlsbad, CA). PCR reactions
were performed on four independent sets of templates.
Relative quantification of gene expression for the 84 gene
targets present in the array was achieved by RT2 Profiler
PCR Array Data Analysis version 3.5 (SABiosciences) using
β-actin as an internal control. Additional normalization was
achieved by feeding the expression values of a panel of
“stem cell genes” including Sox2 and Nestin (stem cell/
proliferation cell marker) and DCX and N-CAM (neuronal
progenitor cells markers) into the software to account for
specific cell loss observed in neurogenic cells. Quantitative
analysis of gene expression was performed in n=4/6
animals/group. Genes were considered as disregulated if
they presented a statistical significant change of 1.2 fold
in expression compared to controls (p<0.05).
Statistical analysis
Data represents mean values ± SEM from at least three in-
dependent experiments. Statistical analysis was performed
using One-way ANOVA followed by the Tukey’s multiple
comparison test or Student’s t test (unpaired; two-tailed)
with a significance of p<0.05 (Prism Graph Pad Software).
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